财务摘要（报告期）（Adamis Pharmaceuticals Corp）
| 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|
| 每股指标： | ||||||
| 每股收益EPS基本(元) | -7.44 | -0.06 | -0.18 | -0.15 | -0.13 | -0.07 |
| 每股净资产(元) | -4.12 | -0.06 | - | 0.02 | 0.05 | 0.11 |
| 每股经营现金净流量(元) | -1.48 | -0.01 | -0.17 | -0.16 | -0.11 | -0.05 |
| 每股现金流量净额(元) | -0.15 | 0.01 | -0.15 | -0.14 | -0.10 | -0.04 |
| 每股营业收入(元) | 0.52 | 0.01 | 0.03 | 0.02 | 0.01 | 0.01 |
| 盈利能力： | ||||||
| 销售毛利率(%) | -47.23 | -23.06 | -30.10 | -42.23 | -80.24 | -26.77 |
| 销售净利率(%) | -1,199.84 | -615.48 | -556.72 | -888.57 | -1,570.03 | -896.88 |
| 净资产收益率平均(%) | 288.44 | 175.78 | -209.88 | -160.29 | -113.91 | -49.56 |
| 总资产净利率(%) | -223.43 | -89.40 | -107.57 | -91.80 | -66.98 | -30.08 |
| 投入资本回报率ROIC(%) | -250.99 | -113.02 | -212.45 | -186.74 | -156.95 | -74.34 |
| 收益质量： | ||||||
| 营业利润／利润总额(%) | 110.70 | 71.30 | 95.65 | 90.88 | 86.85 | 77.66 |
| 经营活动产生的现金流量净额／营业收入(%) | -281.93 | -106.51 | -544.58 | -935.69 | -1,413.34 | -605.08 |
| 资本结构： | ||||||
| 资产负债率(%) | 342.05 | 204.94 | 105.95 | 75.26 | 60.20 | 47.95 |
| 权益乘数 | -0.41 | -0.95 | -16.80 | 4.04 | 2.51 | 1.92 |
| 产权比率 | -1.41 | -1.95 | -17.80 | 3.04 | 1.51 | 0.92 |
| 流动资产／总资产(%) | 72.66 | 83.15 | 84.83 | 83.12 | 86.58 | 90.97 |
| 非流动资产／总资产(%) | 27.34 | 16.85 | 15.17 | 16.88 | 13.42 | 9.03 |
| 流动负债／负债合计(%) | 92.38 | 69.61 | 98.40 | 97.15 | 91.29 | 92.73 |
| 非流动负债／负债合计(%) | 7.62 | 30.39 | 1.60 | 2.85 | 8.71 | 7.27 |
| 归属母公司股东的权益／投入资本(%) | -279.77 | -159.37 | -6.61 | 30.90 | 79.86 | 124.40 |
| 偿债能力： | ||||||
| 流动比率 | 0.23 | 0.58 | 0.81 | 1.14 | 1.58 | 2.05 |
| 速动比率 | 0.19 | 0.53 | 0.70 | 1.01 | 1.53 | 2.04 |
| 货币资金／流动负债(%) | 4.27 | 23.94 | 9.49 | 27.27 | 91.28 | 130.81 |
| 营业利润／流动负债(%) | -118.16 | -49.64 | -219.90 | -233.46 | -165.45 | -58.26 |
| 经营活动产生的现金流量净额／流动负债(%) | -27.43 | -11.95 | -227.28 | -274.71 | -173.59 | -51.43 |
| 归属母公司股东的权益／负债合计(%) | -70.76 | -51.21 | -5.62 | 32.87 | 66.11 | 108.54 |
| 经营活动产生的现金流量净额／负债合计(%) | -25.34 | -8.32 | -223.63 | -266.88 | -158.47 | -47.69 |
| 营业利润／负债合计(%) | -109.16 | -34.56 | -216.37 | -226.80 | -151.04 | -54.02 |
| 成长能力： | ||||||
| 总资产同比增长率(%) | -73.16 | -70.29 | -71.46 | -73.07 | -72.23 | -62.13 |
| 每股净资产同比增长率(%) | -8,873.92 | -153.89 | -102.51 | -91.35 | -85.02 | -71.36 |
| 总负债同比增长率(%) | 52.50 | 26.98 | -6.71 | -13.87 | -37.44 | -42.47 |
| 基本每股收益同比增长率(%) | 15.17 | 14.29 | 43.75 | 42.31 | 27.78 | 41.67 |
| 归属母公司股东的权益同比增长率(%) | -263.24 | -159.90 | -102.51 | -91.29 | -84.91 | -71.19 |
| 营业利润同比增长率(%) | -10.21 | 18.77 | 21.86 | 14.22 | -15.48 | -27.22 |
| 营业收入同比增长率(%) | 22.24 | 25.85 | 115.34 | -22.65 | -54.21 | -17.13 |
| 股东权益合计同比增长率(%) | -263.24 | -159.90 | -102.51 | -91.29 | -84.91 | -71.19 |
| 营运能力： | ||||||
| 存货周转率次(次) | 2.26 | 1.88 | 7.47 | 4.90 | 5.01 | 6.50 |
| 流动资产周转率次(次) | 0.23 | 0.17 | 0.21 | 0.12 | 0.05 | 0.04 |
| 固定资产周转率次(次) | 1.20 | 1.15 | 2.63 | 1.33 | 0.57 | 0.52 |
| 总资产周转率次(次) | 0.19 | 0.15 | 0.19 | 0.10 | 0.04 | 0.03 |
| 衍生指标： | ||||||
| 现金及现金等价物净增加额TTM(元) | -8,211,602.00 | -14,660,083.00 | -22,131,597.00 | -26,316,155.00 | -31,690,912.00 | -40,087,585.00 |
| 利润总额TTM(元) | -23,690,197.00 | -25,022,260.00 | -26,197,406.00 | -30,608,327.00 | -31,505,524.00 | -30,927,043.00 |
| 毛利TTM(元) | -1,162,525.00 | -1,457,406.00 | -1,431,408.00 | -3,924,465.00 | -4,588,523.00 | -4,520,379.00 |
| 投入资本(元) | 4,108,896.00 | 5,976,252.00 | 9,849,476.00 | 9,717,326.00 | 8,818,510.00 | 12,781,297.00 |
| 经营活动产生的现金流量净额TTM(元) | -13,136,193.00 | -20,462,308.00 | -25,900,506.00 | -31,052,107.00 | -33,320,720.00 | -40,234,280.00 |
| 总营业收入TTM(元) | 5,021,662.00 | 5,054,564.00 | 4,756,078.00 | 1,445,961.00 | 794,888.00 | 1,970,097.00 |
| 归属母公司净利润TTM(元) | -25,243,466.00 | -25,066,565.00 | -26,478,273.00 | -31,924,923.00 | -39,887,070.00 | -40,803,579.00 |
| 所得税TTM(元) | 2,000.00 | 2,000.00 | 2,000.00 | 796.00 | 796.00 | 796.00 |